A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin.

about

A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin.

Item

http://www.wikidata.org/entity/Q48194389

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A rat model of FOLFOX-induced ...... ith duloxetine and pregabalin.

@en

A rat model of FOLFOX-induced ...... ith duloxetine and pregabalin.

@nl

type

Item

label

A rat model of FOLFOX-induced ...... ith duloxetine and pregabalin.

@en

A rat model of FOLFOX-induced ...... ith duloxetine and pregabalin.

@nl

prefLabel

A rat model of FOLFOX-induced ...... ith duloxetine and pregabalin.

@en

A rat model of FOLFOX-induced ...... ith duloxetine and pregabalin.

@nl

P1476

A rat model of FOLFOX-induced ...... ith duloxetine and pregabalin.

@en

P2093

Carlo Farina

http://www.w3.org/2001/XMLSchema#string

Laura Micheli

http://www.w3.org/2001/XMLSchema#string

Mario Maresca

http://www.w3.org/2001/XMLSchema#string

Michael W Scherz

http://www.w3.org/2001/XMLSchema#string

P2860

Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity

Dose translation from animal to human studies revisited

A case of 5-fluorouracil-induced peripheral neuropathy.

Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial

Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.

Role of the immune system in chronic pain.

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

Synthesis and biological evaluation of novel dimiracetam derivatives useful for the treatment of neuropathic pain.

Glial activation and pathological pain.

Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance).

P2888

s00280-017-3449-8

P304

1091-1103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-017-3449-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lorenzo Di Cesare Mannelli

Carla Ghelardini

P577

2017-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29026967

http://www.w3.org/2001/XMLSchema#string